Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • Atomo Locks in US$410K Pascal Order as FebriDx Demand Accelerates in the US
    Atomo Locks in US$410K Pascal Order as FebriDx Demand Accelerates in the US
    • News

  • June 2025 quarter CPI no roadblock to August RBA rate cut
    June 2025 quarter CPI no roadblock to August RBA rate cut
    • News

  • Vection Secures $7.3M Defence Extension as AI Demand Strengthens
    Vection Secures $7.3M Defence Extension as AI Demand Strengthens
    • News

  • Calix Secures $44.9m ARENA Grant to Build Green Iron Plant with ZESTY Technology
    Calix Secures $44.9m ARENA Grant to Build Green Iron Plant with ZESTY Technology
    • News

  • Harris Technology boosts retail margins in FY25 through growth of refurbished tech
    Harris Technology boosts retail margins in FY25 through growth of refurbished tech
    • News

  • Lumos Diagnostics Secures US$317M Deal to Distribute FebriDx® in U.S.
    Lumos Diagnostics Secures US$317M Deal to Distribute FebriDx® in U.S.
    • News

  • dorsaVi Powers Ahead with High-Speed RRAM for Smarter Wearables and Edge AI
    dorsaVi Powers Ahead with High-Speed RRAM for Smarter Wearables and Edge AI
    • News

  • Nanoveu Secures $2 Million to Fast-Track Commercial Launch of ECS-DoT Chip and AIoT Platform
    Nanoveu Secures $2 Million to Fast-Track Commercial Launch of ECS-DoT Chip and AIoT Platform
    • News

  • Archer Unlocks Cryogenic Sensor Breakthrough for Quantum Computing
    Archer Unlocks Cryogenic Sensor Breakthrough for Quantum Computing
    • News

  • EGL Secures $1.9M PFAS Plant Contract as Demand for Clean-Up Technologies Surges
    EGL Secures $1.9M PFAS Plant Contract as Demand for Clean-Up Technologies Surges
    • News

Hotel? Alloggio… Or SiteMinder: The two tech based travel stocks to watch

  • In News
  • November 11, 2021
  • Samantha Freidin
Hotel? Alloggio… Or SiteMinder: The two tech based travel stocks to watch

Stepping out of a string of seemingly endless lockdowns into a COVID endemic world hasn’t deterred Aussies from jumping straight back into life as normal. With the holiday period looming people are keen as mustard to get the hell out of dodge and plonk themselves on a beach somewhere for some much needed R&R. 

Qantas recently released a roadmap (aren’t we all sick of that word) to return to international travel which had every hodophile beaming from ear to ear. However, the majority of Australians are likely to ‘holiday at home’, travelling domestically instead of embarking on long haul flights overseas.

Two accommodation based companies are capitalising on investor interest in travel and tourism stocks with debuts on the ASX.

Debuting on the 29th of November is Alloggio (Italian for ‘accomodation’), a company that provides short term accommodation through their portfolio of over 879 properties and 13 hotels, predominantly located in key tourism destinations along the east coast. 

The Company is seeking to raise $16.5 million, giving them a market capitalisation of $40.1 million. Likened to AirBnB, Alloggio has developed their own cloud based platform for property management, booking and dynamic pricing. 

Future growth for the Company is pinned on further development of their platform’s capability, growing their holiday property management rights portfolio via acquisition and organically as well as continued investment in marketing activities to boost brand awareness and market share.

The total addressable market for Alloggio in Australia across all current revenue streams is estimated to be $7.3 billion per year. In FY21, Alloggio generated $11.3 million in revenue and an EBITDA of $4.7 million, representing an increase of 51% and 70% respectively on FY20 despite lockdowns and travel restrictions. 

Australia’s rapidly evolving short term rental market is becoming increasingly competitive with AirBnB holding an estimated 73% of the total market share alongside Expedia Group (39%) and Booking.com (21%). That being said, the attractiveness of Australia as a holiday destination, uptick in digitisation of bookings and research as well as vaccine rollouts and reopening of borders mean that there is plenty of room for travel stocks, especially one that consolidates the fragmented base of short term rental hosts and owners with a professional management and integrated services model. 

Servicing the hotel management sector directly is SiteMinder (ASX: SDR), a leading open hotel commerce platform. The Company commenced trading on the ASX on November 8th following an oversubscribed IPO of $627 million. Their market cap sits at a hefty $1.36 billion. Their revenue also remained largely unharmed through the pandemic, with a total annual revenue of $101 million achieved in FY21.  

Established in Australia in 2006, SiteMinder has pioneered the opening of hotel access to online commerce with over 32,000 hotels, across 150 countries using their platform to sell, market, manage and grow their businesses. Their platform enables hotels to integrate all their software needs into one with an online booking engine, hotel website design tool, access to business insights and payment processing, to name a few. 

The global company has offices worldwide and has helped generate over USD $35 billion in hotel revenue over the last year. 

With the digitisation of almost every service and industry accelerated by the pandemic, these two stocks are set to go head-to-head upon their ASX debuts, vying for market share in the multi billion dollar travel industry and investors. 

  • About
  • Latest Posts
Samantha Freidin
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial - September 1, 2022
  • How this company is developing medtech to support Indigenous community health - August 22, 2022
  • A round of ap-paws for PharmAust, changing the ruff prognosis for dogs with lymphoma - August 17, 2022
  •  
  •  
  •  
  •  
  • News

Leave a Comment

You must be logged in to post a comment.

  • About
  • Latest Posts
Samantha Freidin
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial - September 1, 2022
  • How this company is developing medtech to support Indigenous community health - August 22, 2022
  • A round of ap-paws for PharmAust, changing the ruff prognosis for dogs with lymphoma - August 17, 2022

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Samantha Freidin
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial - September 1, 2022
  • How this company is developing medtech to support Indigenous community health - August 22, 2022
  • A round of ap-paws for PharmAust, changing the ruff prognosis for dogs with lymphoma - August 17, 2022
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.